Europe
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
These life sciences companies scored enough capital this week for pumpkin spice and everything nice, and to propel their candidates in the clinic. Here’s a look.
The deal’s termination was announced Thursday, months after bintrafusp alfa failed to hit the mark in a Phase II clinical trial as a potential second-line treatment for metastatic biliary tract cancer.
It was a busy week for clinical trial news. Here’s a look.
First COVID-19, now cancer. BioNTech made history when its COVID-19 mRNA vaccine with partner Pfizer became the first ever approved.
Biopharma companies and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
Ferring Pharmaceuticals today announced positive results across all five of its prospective trials for a live biotherapeutic designed to reduce recurrent C. difficile infection (rCDI).
Teva Pharmaceuticals reached a $15 million agreement with the state of Louisiana to settle claims against the company over its marketing of opioid products.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Celyad is focusing on advancing chimeric antigen receptor T cell (CAR T) therapies.
PRESS RELEASES